Texas Urologist Will Head National Cancer Institute

Cancer leaders embraced President George W. Bush's appointment Dec. 6 of Texas urologist Andrew von Eschenbach to head the National Cancer Institute (NCI). In no uncertain terms, they praised von Eschenbach's political know-how, consensus-building skills, and openness to promoting all facets of a nationwide cancer agenda. Trish Strangmeyer PhotographyAndrew von Eschenbach A urologic surgeon, von Eschenbach directed the Genitourinary Cancer Center and Prostate Cancer Research Center at the Univer

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A urologic surgeon, von Eschenbach directed the Genitourinary Cancer Center and Prostate Cancer Research Center at the University of Texas M.D. Anderson Cancer Center in Houston. When his appointment was announced, von Eschenbach was also president-elect of the American Cancer Society and a founder of the National Dialogue on Cancer, a national forum and public-private partnership devoted to spearheading a national cancer agenda. The National Dialogue on Cancer was established in 1998 in conjunction through the American Cancer Society, American Society of Clinical Oncology, the Centers for Disease Control and Prevention, industry, and other partners. President Bush and First Lady Laura Bush chair the group, U.S. Sen. Diane Feinstein (D-Calif.) is vice chair, and Tom Ridge, former Pennsylvania governor and now director of homeland security at the White House, was an early collaborating partner. Although to a certain extent, people acknowledged that von Eschenbach, a close confidante of the Bush ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Laura Newman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours